The following strains were used : Escherichia coli DH5 [ 80dlacZ M15 ( lacZYA - argF ) U169 recA1 endA1 hsdR17 ( r m K K ) supE44 thi - 1 gyrA relA1 ] , a standard laboratory strain used for DNA manipulation ; S. enterica serovar Typhimurium STM - 1 ( aroA serC ) , an attenuated vaccine strain ( 1 ) ; S. enterica serovar Enteriditis SEM - 2 ( aroA aroD ) , an attenuated strain ; and J774 .2 , a murine macrophage cell line used in Salmonella uptake experiments .

List of plasmid vectors used in this study Description Vector Reference or source 2.96 - kb phagemid ; LacZ Ampr 3.9 - kb PCR cloning plasmid ; Ampr Kanr ; 3 T overhang Eukaryotic expression vector expressing ovalbumin Prokaryotic expression vector expressing ovalbumin pCR2 .1 containing nirB promoter pCR2 .1 containing chicken ovalbumin gene pCR2 .1 containing pagC promoter pCR2 .1 containing Ova gene under the control of the nirB promoter pCR2 .1 containing Ova gene under the control of the pagC promoter 4.4 - kb phagemid ; LacZ Ampr Kanr pMW2 containing Ova gene under the control of the nirB promoter pMW2 containing Ova gene under the control of the pagC promoter 3.4 - kb plasmid ; oriR6K tL3 ( Ter ) bla ( ApR ) kan rgn ( Ter ) pKD13 containing Ova gene under the control of the nirB promoter pKD13 containing Ova gene under the control of the pagC promoter 6.3 - kb plasmid ; repA101 ( ts ) araBp - gam - bet - exo bla ( ApR ) oriR101 pBluescript IIKS pCR2 .1 sOVA - C1 pKK - Ova pCRnirB pCROva pCRpagC pCRnirBOva pCRpagCOva pMW2 pMnirBOva pMpagCOva pKD13 pKnirBOva pKpagCOva pKD46 Stratagene Invitrogen , Australia 14 28 This study This study This study This study This study M. Wosten This study This study 24 This study This study 24 2 ) .

Oligonucleotide primersa Primer name Sequence ( 5 3 3 ) Binding site Enzyme Reference OVA FWD OVA REV PAGFWD PAGCREV NIRBFWD NIRBREV M13 REV M13 - 20 EcoRI EcoRI BamHI MfeI BamHI MfeI This study This study 28 28 28 28 GGAATTCCATGGGCTCCATCGGTGCAG GGAATTCTGGGTCTTGTTGGAAGGG CTCTGGATCCTAATGGGTTTATAGCG AATAGATCCAATTGCAACTCCTTAAT GCCGGATCCTTGAACATAGTGGTCCGC GACTTTGCCAATTGTTGCCTCGATTC CAGGAAACAGCTATGAC GTAAAACGACGGCCAG 5 Ova 3 Ova 5 pagC gene promoter 3 pagC gene promoter 5 nirB gene promoter 3 nirB gene promoter Sequencing primer Sequencing primer a Restriction sites are underlined .

Inﬂuence of preexisting immunitya Vaccination Group Week 0 Week 3 Week 12 None None 1 STM - 1 None None None None 2 STM - 1 / pKKOva STM - 1 / pKKOva STM - 1 / pKKOva STM - 1 S. enterica serovar Enteritidis None None STM - 1 S. enterica serovar Enteritidis 3 4 None None None None 5 STM - 1 6 STM - 1 / pKKOva STM - 1 / pKKOva STM - 1 / pKKOva 7 8 The inﬂuence of preexisting immunity on immune responses induced to vectored antigen .

